Table 2. IC50 of hep-ATIII in different liposome formulations.
Formulation | HIV-1 isolate | IC50 (nM) |
Free hep-ATIII control | 89.6 | 60 |
SF162 | 75 | |
Conventional Liposomes | 89.6 | 24 |
SF162 | 22 | |
ET-ATIII | 89.6 | 0.4 |
SF162 | 0.7 |
Formulation | HIV-1 isolate | IC50 (nM) |
Free hep-ATIII control | 89.6 | 60 |
SF162 | 75 | |
Conventional Liposomes | 89.6 | 24 |
SF162 | 22 | |
ET-ATIII | 89.6 | 0.4 |
SF162 | 0.7 |